← Leaderboards
Jawahar L Mehta
Central Arkansas Veterans Hlthcare Sys
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2009–22$1$1$1$0$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Central Arkansas Veterans Hlthcare Sys
Same institution · by research overlap
- Alexei G Basnakian$3,611,011
- Andrew J Morris$11,108,633
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMouse ModelAtherogenesisSignal TransductionBaseLow-Density LipoproteinsInhibitor/AntagonistCardiovascular SystemIn VitroExposure ToMonocyteLaboratoriesIn VivoInflammatoryAtherosclerosisGrowthEventChronicBlood VesselsCoronary ArteryDesignEndothelial CellsArterial Fatty StreakCells
Grant awards (12)
PCSK9-A novel target for the treatment of myocardial ischemia$0
I01 · FY2022 · VA · contact PI
PCSK9-A novel target for the treatment of myocardial ischemia$0
I01 · FY2021 · VA · contact PI
PCSK9-A novel target for the treatment of myocardial ischemia$0
I01 · FY2020 · VA · contact PI
PCSK9-A novel target for the treatment of myocardial ischemia$0
I01 · FY2019 · VA · contact PI
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.$0
I01 · FY2017 · VA · contact PI
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.$0
I01 · FY2016 · VA · contact PI
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.$0
I01 · FY2015 · VA · contact PI
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.$0
I01 · FY2014 · VA · contact PI
Oxidized-LDL, LOX-1 and angiogenesis$0
I01 · FY2013 · VA · contact PI
Oxidized-LDL, LOX-1 and angiogenesis$0
I01 · FY2012 · VA · contact PI
Oxidized-LDL, LOX-1 and angiogenesis$0
I01 · FY2011 · VA · contact PI
Oxidized-LDL, LOX-1 and angiogenesis$0
I01 · FY2009 · VA · contact PI